1. Magnetic Resonance - Technology Information Portal. Resovist®. [consultado Jun 2013].Disponible en: http://www.mr-tip.com/serv1.php?type=db1&dbs=Resovist%AE.
2. European Medicines Agency. Questions and answers on the withdrawal of the marketing application for Sinerem. [Jun 2013].Disponible en: http://www.emea.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500015294.pdf. Publicado el 24 de enero de 2008.
3. European Medicines Agency. Public statement on Teslascan (mangafodipir) Publicado el 18 de julio de 2012 [consultado Jun 2013]. Disponible en: http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2012/08/WC500130495.pdf.
4. Magnetic Resosnance - Technology Information Portal. MRI Contrast Agents Overview. [consultado Jun 2013]. Disponible en: http://www.mr-tip.com/serv1.php?type=coa&sub=1.
5. Extracellular gadolinium contrast agents: differences in stability;Morcos;Eur J Radiol,2008